Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06240312 · ClinicalTrials.gov registry record · NA
Optic Nerve Head Strain as Biomarker for Glaucoma
A NA study of Glaucoma Open-Angle, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT06240312: Recruiting NA study of Glaucoma Open-Angle, sponsored by Johns Hopkins University.
NCT06240312 is a NA study of Glaucoma Open-Angle that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 130 participants, below the 159-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06240312, a NA study of Glaucoma Open-Angle, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.
Primary Outcome
Strains measured at baseline are tested for association with glaucoma course
Conditions Studied
Interventions
- DEVICE Images of eye at 2 eye pressures
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT06240312 shows while recruiting
NCT06240312 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 159-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 1 intervention - of which Images of eye at 2 eye pressures is the first listed.
NCT06240312 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06240312 about?
NCT06240312 is a clinical study titled "Optic Nerve Head Strain as Biomarker for Glaucoma". The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.
What is the current status of trial NCT06240312?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2024-07-01. Estimated completion is 2028-01-31.
What conditions does trial NCT06240312 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT06240312?
The interventions under investigation include: Images of eye at 2 eye pressures (DEVICE).
Who is sponsoring clinical trial NCT06240312?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06240312 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06240312's enrollment target sits among peer trials
130 11th of 22 higher than 12 of 22 other Glaucoma Open-Angle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma Open-Angle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
A Trial of Hydrus Microstent Versus Goniotomy
RECRUITING · NA
-
Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI